126 related articles for article (PubMed ID: 27594528)
1. A new brominated chalcone derivative suppresses the growth of gastric cancer cells in vitro and in vivo involving ROS mediated up-regulation of DR5 and 4 expression and apoptosis.
Zhang S; Li T; Zhang Y; Xu H; Li Y; Zi X; Yu H; Li J; Jin CY; Liu HM
Toxicol Appl Pharmacol; 2016 Oct; 309():77-86. PubMed ID: 27594528
[TBL] [Abstract][Full Text] [Related]
2. A novel chalcone derivative S17 induces apoptosis through ROS dependent DR5 up-regulation in gastric cancer cells.
Zhang S; Li T; Zhang L; Wang X; Dong H; Li L; Fu D; Li Y; Zi X; Liu HM; Zhang Y; Xu H; Jin CY
Sci Rep; 2017 Aug; 7(1):9873. PubMed ID: 28852176
[TBL] [Abstract][Full Text] [Related]
3. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.
Lim SC; Duong HQ; Choi JE; Lee TB; Kang JH; Oh SH; Han SI
Carcinogenesis; 2011 May; 32(5):723-31. PubMed ID: 21362627
[TBL] [Abstract][Full Text] [Related]
4. The chalcone 2'-hydroxy-4',5'-dimethoxychalcone activates death receptor 5 pathway and leads to apoptosis in human nonsmall cell lung cancer cells.
Yang L; Su L; Cao C; Xu L; Zhong D; Xu L; Liu X
IUBMB Life; 2013 Jun; 65(6):533-43. PubMed ID: 23554101
[TBL] [Abstract][Full Text] [Related]
5. Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
Park MH; Jo M; Won D; Song HS; Song MJ; Hong JT
Apoptosis; 2012 Dec; 17(12):1316-26. PubMed ID: 23007278
[TBL] [Abstract][Full Text] [Related]
6. An agonistic antibody to human death receptor 4 induces apoptotic cell death in head and neck cancer cells through mitochondrial ROS generation.
Lee BS; Kang SU; Hwang HS; Kim YS; Sung ES; Shin YS; Lim YC; Kim CH
Cancer Lett; 2012 Sep; 322(1):45-57. PubMed ID: 22353688
[TBL] [Abstract][Full Text] [Related]
7. Betulin induces reactive oxygen species-dependent apoptosis in human gastric cancer SGC7901 cells.
Li Y; Liu X; Jiang D; Lin Y; Wang Y; Li Q; Liu L; Jin YH
Arch Pharm Res; 2016 Sep; 39(9):1257-65. PubMed ID: 27271333
[TBL] [Abstract][Full Text] [Related]
8. Phenethyl isothiocyanate enhances TRAIL-induced apoptosis in oral cancer cells and xenografts.
Yeh CC; Ko HH; Hsieh YP; Wu KJ; Kuo MY; Deng YT
Clin Oral Investig; 2016 Dec; 20(9):2343-2352. PubMed ID: 26822174
[TBL] [Abstract][Full Text] [Related]
9. Novel 3-(2,6,9-trisubstituted-9H-purine)-8-chalcone derivatives as potent anti-gastric cancer agents: Design, synthesis and structural optimization.
Zhao TQ; Zhao YD; Liu XY; Li ZH; Wang B; Zhang XH; Cao YQ; Ma LY; Liu HM
Eur J Med Chem; 2019 Jan; 161():493-505. PubMed ID: 30388465
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumour activity of a novel coumarin-chalcone hybrid is mediated through intrinsic apoptotic pathway by inducing PUMA and altering Bax/Bcl-2 ratio.
Singh N; Sarkar J; Sashidhara KV; Ali S; Sinha S
Apoptosis; 2014 Jun; 19(6):1017-28. PubMed ID: 24638227
[TBL] [Abstract][Full Text] [Related]
11. Hesperetin Induces the Apoptosis of Gastric Cancer Cells via Activating Mitochondrial Pathway by Increasing Reactive Oxygen Species.
Zhang J; Wu D; Vikash ; Song J; Wang J; Yi J; Dong W
Dig Dis Sci; 2015 Oct; 60(10):2985-95. PubMed ID: 25972151
[TBL] [Abstract][Full Text] [Related]
12. Acrolein sensitizes human renal cancer Caki cells to TRAIL-induced apoptosis via ROS-mediated up-regulation of death receptor-5 (DR5) and down-regulation of Bcl-2.
Yang ES; Woo SM; Choi KS; Kwon TK
Exp Cell Res; 2011 Nov; 317(18):2592-601. PubMed ID: 21854768
[TBL] [Abstract][Full Text] [Related]
13. NG as a novel nitric oxide donor induces apoptosis by increasing reactive oxygen species and inhibiting mitochondrial function in MGC803 cells.
Liu L; Li T; Tan J; Fu J; Guo Q; Ji H; Zhang Y
Int Immunopharmacol; 2014 Nov; 23(1):27-36. PubMed ID: 25135879
[TBL] [Abstract][Full Text] [Related]
14. [Cisplatin enhances TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts].
Xu L; Qu XJ; Liu YP; Liu J; Zhang Y; Hou KZ; Jiang YH
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):484-8. PubMed ID: 22093622
[TBL] [Abstract][Full Text] [Related]
15. Isoobtusilactone A sensitizes human hepatoma Hep G2 cells to TRAIL-induced apoptosis via ROS and CHOP-mediated up-regulation of DR5.
Chen CY; Yiin SJ; Hsu JL; Wang WC; Lin SC; Chern CL
J Agric Food Chem; 2012 Apr; 60(13):3533-9. PubMed ID: 22400995
[TBL] [Abstract][Full Text] [Related]
16. Licochalcone A-induced human gastric cancer BGC-823 cells apoptosis by regulating ROS-mediated MAPKs and PI3K/AKT signaling pathways.
Hao W; Yuan X; Yu L; Gao C; Sun X; Wang D; Zheng Q
Sci Rep; 2015 May; 5():10336. PubMed ID: 25981581
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
[TBL] [Abstract][Full Text] [Related]
18. Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
Ohtsuki T; Kikuchi H; Koyano T; Kowithayakorn T; Sakai T; Ishibashi M
Bioorg Med Chem; 2009 Sep; 17(18):6748-54. PubMed ID: 19682913
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
[TBL] [Abstract][Full Text] [Related]
20. 4-XL-PPD, a novel ginsenoside derivative, as potential therapeutic agents for gastric cancer shows anti-cancer activity via inducing cell apoptosis medicated generation of reactive oxygen species and inhibiting migratory and invasive.
Wang X; Sun YY; Qu FZ; Su GY; Zhao YQ
Biomed Pharmacother; 2019 Oct; 118():108589. PubMed ID: 31382131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
